Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limitedverified

T14.SI

Price:

$2.43

Market Cap:

$22.47B

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceut...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-01-03

Stock Exchange

SES

Ticker

T14.SI

The Current Ratio as of July 2025 (TTM) for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is 2.00

According to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.00. This represents a change of 5.29% compared to the average of 1.90 of the last 4 quarters.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Historical Current Ratio (quarterly & annually)

How has T14.SI Current Ratio performed in the past?

The mean historical Current Ratio of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited over the last ten years is 2.30. The current 2.00 Current Ratio has changed 8.61% with respect to the historical average. Over the past ten years (40 quarters), T14.SI's Current Ratio was at its highest in in the March 2022 quarter at 2.65. The Current Ratio was at its lowest in in the June 2024 quarter at 1.56.

Quarterly (TTM)
Annual

Average

2.30

Median

2.26

Minimum

2.02

Maximum

2.64

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 51.74%

Maximum Annual Current Ratio = 2.64

Minimum Annual Increase = -17.66%

Minimum Annual Current Ratio = 2.02

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.3515.72%
20232.03-6.76%
20222.17-17.66%
20212.641.94%
20202.598.80%
20192.38-4.69%
20182.5017.37%
20172.135.44%
20162.02-7.12%
20152.1751.74%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Average Current Ratio

How has T14.SI Current Ratio performed in the past?

The current Current Ratio of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.18

5-year avg

2.35

10-year avg

2.30

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Current Ratio vs. Peers

How is T14.SI’s Current Ratio compared to its peers?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s Current Ratio is greater than Yanlord Land Group Limited (1.22), less than Haw Par Corporation Limited (31.38), greater than China Aviation Oil (Singapore) Corporation Ltd (1.71), less than Q & M Dental Group (Singapore) Limited (0), less than null (2.64),

Build a custom stock screener for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's Current Ratio?

How is the Current Ratio calculated for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the highest Current Ratio for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 3-year average Current Ratio for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 5-year average Current Ratio for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

How does the current Current Ratio for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) compare to its historical average?